Literature DB >> 2154746

Site-specific excision from RNA by RNase H and mixed-phosphate-backbone oligodeoxynucleotides.

S Agrawal1, S H Mayrand, P C Zamecnik, T Pederson.   

Abstract

Oligodeoxynucleotides containing phosphodiester or modified internucleoside linkages were investigated with respect to their ability to be acted on by ribonuclease H activities present in a HeLa cell nuclear extract after hybridization with complementary sequences in RNA. Oligodeoxynucleotides complementary to nucleotides 2-14 of human U1 small nuclear RNA were investigated. Extensive cleavage of U1 RNA was observed with the unmodified oligodeoxynucleotide and with the phosphorothioate analogue but not with U1-complementary oligodeoxynucleotides containing methylphosphonate, phosphoro-N-morpholidate, or phosphoro-N-butylamidate internucleoside linkages. Additional experiments using a 514-nucleotide-long RNA substrate demonstrated the capacity of complementary phosphodiester- and phosphorothioate-linked oligodeoxynucleotides (but not ones containing methylphosphonate, phosphoro-N-morpholidate, or phosphoro-N-butylamidate linkages) to serve as RNase H targets when hybridized to an internal RNA site. Detailed comparisons revealed phosphodiester-linked oligodeoxynucleotides to be more efficient than the comparable phosphorothioate-linked oligomers with respect to RNase H action. Various pentadecamer oligodeoxynucleotides complementary to the 514-nucleotide-long test RNA and containing 2-6 consecutive phosphodiester- or phosphorothioate-linked nucleotides flanked by RNase H-resistant methylphosphonate linkages afforded precise "site-directed" RNase H excision within the DNA.RNA hybrid. These results serve to assort modified oligodeoxynucleotide-containing hybrids into RNase H-sensitive and -resistant classes and also provide clues as to how RNase H makes contact with the DNA strand in a DNA.RNA hybrid.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2154746      PMCID: PMC53483          DOI: 10.1073/pnas.87.4.1401

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Sequence-dependent hydrolysis of RNA using modified oligonucleotide splints and RNase H.

Authors:  H Inoue; Y Hayase; S Iwai; E Ohtsuka
Journal:  FEBS Lett       Date:  1987-05-11       Impact factor: 4.124

2.  RNase H cleavage of RNA hybridized to oligonucleotides containing methylphosphonate, phosphorothioate and phosphodiester bonds.

Authors:  P J Furdon; Z Dominski; R Kole
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

3.  Reconstitution of the U1 small nuclear ribonucleoprotein particle.

Authors:  J R Patton; R J Patterson; T Pederson
Journal:  Mol Cell Biol       Date:  1987-11       Impact factor: 4.272

4.  The Mr 70,000 protein of the U1 small nuclear ribonucleoprotein particle binds to the 5' stem-loop of U1 RNA and interacts with Sm domain proteins.

Authors:  J R Patton; T Pederson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

5.  Enzymatic amplification of translation inhibition of rabbit beta-globin mRNA mediated by anti-messenger oligodeoxynucleotides covalently linked to intercalating agents.

Authors:  C Cazenave; N Loreau; N T Thuong; J J Toulmé; C Hélène
Journal:  Nucleic Acids Res       Date:  1987-06-25       Impact factor: 16.971

6.  Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5.

Authors:  C C Smith; L Aurelian; M P Reddy; P S Miller; P O Ts'o
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

Review 7.  Oligodeoxynucleotides as inhibitors of gene expression: a review.

Authors:  C A Stein; J S Cohen
Journal:  Cancer Res       Date:  1988-05-15       Impact factor: 12.701

8.  Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.

Authors:  M Matsukura; K Shinozuka; G Zon; H Mitsuya; M Reitz; J S Cohen; S Broder
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

9.  Comparative hybrid arrest by tandem antisense oligodeoxyribonucleotides or oligodeoxyribonucleoside methylphosphonates in a cell-free system.

Authors:  L J Maher; B J Dolnick
Journal:  Nucleic Acids Res       Date:  1988-04-25       Impact factor: 16.971

10.  Physicochemical properties of phosphorothioate oligodeoxynucleotides.

Authors:  C A Stein; C Subasinghe; K Shinozuka; J S Cohen
Journal:  Nucleic Acids Res       Date:  1988-04-25       Impact factor: 16.971

View more
  30 in total

1.  Molecular requirements for degradation of a modified sense RNA strand by Escherichia coli ribonuclease H1.

Authors:  Daniel R Yazbeck; Kyung-Lyum Min; Masad J Damha
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

2.  Physical properties of oligonucleotides containing phosphoramidate-modified internucleoside linkages.

Authors:  J M Dagle; M E Andracki; R J DeVine; J A Walder
Journal:  Nucleic Acids Res       Date:  1991-04-25       Impact factor: 16.971

3.  Localization of pre-messenger RNA at discrete nuclear sites.

Authors:  J Wang; L G Cao; Y L Wang; T Pederson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

4.  Mixed backbone antisense oligonucleotides: design, biochemical and biological properties of oligonucleotides containing 2'-5'-ribo- and 3'-5'-deoxyribonucleotide segments.

Authors:  E R Kandimalla; A Manning; Q Zhao; D R Shaw; R A Byrn; V Sasisekharan; S Agrawal
Journal:  Nucleic Acids Res       Date:  1997-01-15       Impact factor: 16.971

5.  Targeted elimination of zygotic messages in Xenopus laevis embryos by modified oligonucleotides possessing terminal cationic linkages.

Authors:  J M Dagle; J L Littig; L B Sutherland; D L Weeks
Journal:  Nucleic Acids Res       Date:  2000-05-15       Impact factor: 16.971

6.  Effects of RNA secondary structure on cellular antisense activity.

Authors:  T A Vickers; J R Wyatt; S M Freier
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

7.  Antimalarial activities of oligodeoxynucleotide phosphorothioates in chloroquine-resistant Plasmodium falciparum.

Authors:  E Rapaport; K Misiura; S Agrawal; P Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

8.  Reversal of cystic fibrosis phenotype in a cultured Delta508 cystic fibrosis transmembrane conductance regulator cell line by oligonucleotide insertion.

Authors:  Paul C Zamecnik; Malay K Raychowdhury; David R Tabatadze; Horacio F Cantiello
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

9.  Antisense oligodeoxynucleotides: synthesis, biophysical and biological evaluation of oligodeoxynucleotides containing modified pyrimidines.

Authors:  Y S Sanghvi; G D Hoke; S M Freier; M C Zounes; C Gonzalez; L Cummins; H Sasmor; P D Cook
Journal:  Nucleic Acids Res       Date:  1993-07-11       Impact factor: 16.971

10.  Intracellular disposition and metabolism of fluorescently-labeled unmodified and modified oligonucleotides microinjected into mammalian cells.

Authors:  T L Fisher; T Terhorst; X Cao; R W Wagner
Journal:  Nucleic Acids Res       Date:  1993-08-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.